Compare Citius Pharmaceuticals Inc (CTXR) vs Uber Technologies Inc (UBER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Uber Technologies Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while Uber Technologies Inc trades at $72.55 (market cap $151.16B). The key difference: Uber Technologies Inc is far larger — about 10192.9× Citius Pharmaceuticals Inc's market cap, and Uber Technologies Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | UBER | |
|---|---|---|
Market Cap | $14.83M | $151.16B |
Sector | Health | Industrials |
52-Week High | $1.82 | $100.10 |
52-Week Low | $0.53 | $68.61 |
Enterprise Value | $11.05M | $157.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Uber (UBER) trades at $72.08, down 3.3% over the past 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong revenue growth to $52.02B in 2025 and a net income of $10.05B, though Q4 2025 earnings missed expectations. Recent news highlights strategic moves into autonomous vehicles, including robotaxi pilots in Madrid and Munich, alongside cost-cutting measures such as HR layoffs and AI spending caps.
The outlook remains positive with an 81.67% analyst buy rating and a consensus price target of $108.92, suggesting significant upside. Key risks include execution challenges in autonomous driving, competitive pressures in key markets like India, and potential regulatory hurdles. Investors should weigh strong fundamentals against evolving industry dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →
